Blue Sphere Health

Patient engagement

Patient Engagement Traceability is coming to almost all major pharmaceutical markets. The Falsified Medicine Directive (FMD) in the European Union, Drug Supply Chain Security Act (DSCSA) in the USA, and many similar legislative and regulatory moves elsewhere will mean that all manufacturers need to think differently about their products. This presents a challenge (which we can help you with) but it also gives you an opportunity to reach customers in new ways. The datamatrix codes used for serialisation can be scanned by almost any mobile phone camera. This gives opportunities not only for initial code verification but also for an extended conversation with the patient. If you are designing or reviewing your strategy for patient engagement we’ll help you to consider the huge opportunities that the next five years will bring. In parallel with the widespread penetration of basic smart phones (with cameras) to consumers even in developing markets, the rise of coded packs will make new business models possible. Your competitors are exploring them. Don’t get left behind. Contact us today.

Contact Us

Your Name (required)

Your Email (required)

Subject

Your Message

Pharmaceutical Anti-Counterfeiting

Combating the Real Danger from Fake Drugs has become a must-have primer on anti-counterfeiting and is widely used by drug companies, regulators and others. The book covers the legal, strategic and political issues as well as the technical counter-measures such as process control, digital serialisation and physical security.


Pharmaceutical Anti-Counterfeiting book